Session 3: Update on the Pharmacotherapy of Alzheimer's, Major Depressive and Bipolar Disorders

Date: 2/17/2012 Check-In and Breakfast:
 7:00 am - 7:30 am
Educational Session: 7:30 am - 1:00 pm
Edward Fisher, Ph.D.,R.Ph. Professor of Pharmacology and Toxicology and Associate Dean for Academic Affairs University of Hawaii at Hilo College of Pharmacy , Live CME Instructor for University Learning Systems

Edward Fisher, Ph.D., R.Ph., Professor of Pharmacology and Toxicology, Associate Dean for  Academic Affairs, Director of the MS in Psychopharmacology Program, College of Pharmacy, University of Hawaii at Hilo. Disclosure: Dr. Fisher  has no financial arrangements with any corporate organization that might have an interest in the subject being presented.

At the conclusion of this program, the participant will be able to:

  • Recall the diagnostic criteria used for the disorders discussed;
  • Explain the current theories on the etiology of the disorders discussed;
  • Describe the various clinical symptoms associated with these disease states;
  • Discuss the prognosis and epidemiology of these disease states;
  • Implement appropriate pharmacotherapy for the disorders discussed;
  • Describe the typical course of the disease processes and the stages of cognitive decline associated with Alzheimer’s disease;
  • Compare and contrast the efficacy of the drugs used for each disorder discussed;
  • Recall the pharmacological properties of the drugs used to treat these disorders;
  • List the adverse effects associated with the drugs commonly used to treat these disorders.